TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Market Overview
1.22025 Market Size and 2035 Forecast
1.3Largest and Fastest-Growing Segments
1.4Key Country and Regional Highlights
1.5Competitive Positioning
1.6Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Market Definitions and Boundaries
2.2Base Year and Forecast Period
2.3Primary Research
2.4Secondary Research
2.5Bottom-Up Market Estimation
2.6Top-Down Market Estimation
2.7Data Triangulation
2.8Forecast Assumptions and Limitations
Chapter 3 — Market Dynamics
3.1Growth Drivers
3.2Market Restraints
3.3Growth Opportunities
3.4Industry Challenges
3.5Emerging Trends
3.6Porter’s Five Forces
3.7Value Chain and Pricing Analysis
Chapter 4 — Technology, Regulatory and Commercial Landscape
4.1Technology Evolution
4.2Product Innovation and Pipeline
4.3Regulatory Approvals and Compliance
4.4Clinical and Performance Evidence
4.5Reimbursement and Payer Access
4.6Distribution and Procurement
4.7Digital Integration and Interoperability
Chapter 5 — Market Size and Forecast, 2025–2035
5.1Market Revenue, 2025–2035
5.2Year-on-Year Growth and CAGR
5.3Revenue by Segment
5.4Largest Segment and Growth Rationale
5.5Fastest-Growing Segment and Growth Rationale
5.6Forecast Scenarios and Sensitivities
Chapter 6 — Market Analysis, by Product
6.1Overview and Market Definition
6.2Revenue and Forecast, 2025–2035
6.3Subsegment Analysis
6.3.1Meters
6.3.2Test Strips
6.3.3Lancets and Lancing Devices
6.3.4Connected Accessories
6.4Largest Subsegment: Share and Drivers
6.5Fastest-Growing Subsegment: CAGR and Drivers
6.6Competitive and Commercial Implications
Chapter 7 — Market Analysis, by Technology
7.1Overview and Market Definition
7.2Revenue and Forecast, 2025–2035
7.3Subsegment Analysis
7.3.1Electrochemical
7.3.2Photometric
7.3.3Connected and Bluetooth-Enabled
7.4Largest Subsegment: Share and Drivers
7.5Fastest-Growing Subsegment: CAGR and Drivers
7.6Competitive and Commercial Implications
Chapter 8 — Market Analysis, by Patient Type
8.1Overview and Market Definition
8.2Revenue and Forecast, 2025–2035
8.3Subsegment Analysis
8.3.1Type 1 Diabetes
8.3.2Type 2 Diabetes
8.3.3Other Users
8.4Largest Subsegment: Share and Drivers
8.5Fastest-Growing Subsegment: CAGR and Drivers
8.6Competitive and Commercial Implications
Chapter 9 — Market Analysis, by End User
9.1Overview and Market Definition
9.2Revenue and Forecast, 2025–2035
9.3Subsegment Analysis
9.3.1Homecare
9.3.2Hospitals and Clinics
9.4Largest Subsegment: Share and Drivers
9.5Fastest-Growing Subsegment: CAGR and Drivers
9.6Competitive and Commercial Implications
Chapter 10 — Market Analysis, by Distribution Channel
10.1Overview and Market Definition
10.2Revenue and Forecast, 2025–2035
10.3Subsegment Analysis
10.3.1Retail Pharmacy
10.3.2Hospital Pharmacy
10.3.3Online
10.4Largest Subsegment: Share and Drivers
10.5Fastest-Growing Subsegment: CAGR and Drivers
10.6Competitive and Commercial Implications
Chapter 11 — Regional and Country Market Analysis
11.1Regional Market Share and Forecast, 2025–2035
11.2North America
11.2.1United States
11.2.2Canada
11.2.3Mexico
11.3Europe
11.3.1Germany
11.3.2United Kingdom
11.3.3France
11.3.4Italy
11.3.5Spain
11.3.6Netherlands
11.3.7Switzerland
11.3.8Nordic Countries
11.3.9Rest of Europe
11.4Asia Pacific
11.4.1China
11.4.2Japan
11.4.3India
11.4.4South Korea
11.4.5Australia
11.4.6Southeast Asia
11.4.7Rest of Asia Pacific
11.5Latin America
11.5.1Brazil
11.5.2Argentina
11.5.3Chile
11.5.4Colombia
11.5.5Rest of Latin America
11.6Middle East & Africa
11.6.1Saudi Arabia
11.6.2United Arab Emirates
11.6.3South Africa
11.6.4Turkey
11.6.5Rest of Middle East & Africa
11.7Largest Geography and Underlying Drivers
11.8Fastest-Growing Geography and Underlying Drivers
Chapter 12 — Competitive Landscape
12.1Competitive Structure
12.2Market Share and Concentration
12.3Product and Technology Benchmarking
12.4Pricing and Distribution Benchmarking
12.5Mergers and Acquisitions
12.6Partnerships and Collaborations
12.7New Product Launches
12.8Geographic Expansion
Chapter 13 — Company Profiles
13.1Roche Diabetes Care
13.1.1Company Overview
13.1.2Relevant Product and Service Portfolio
13.1.3Financial Performance (Where Disclosed)
13.1.4Geographic Presence
13.1.5Recent Strategic Developments
13.1.6SWOT and Competitive Positioning
13.2LifeScan
13.2.1Company Overview
13.2.2Relevant Product and Service Portfolio
13.2.3Financial Performance (Where Disclosed)
13.2.4Geographic Presence
13.2.5Recent Strategic Developments
13.2.6SWOT and Competitive Positioning
13.3Ascensia Diabetes Care
13.3.1Company Overview
13.3.2Relevant Product and Service Portfolio
13.3.3Financial Performance (Where Disclosed)
13.3.4Geographic Presence
13.3.5Recent Strategic Developments
13.3.6SWOT and Competitive Positioning
13.4Abbott
13.4.1Company Overview
13.4.2Relevant Product and Service Portfolio
13.4.3Financial Performance (Where Disclosed)
13.4.4Geographic Presence
13.4.5Recent Strategic Developments
13.4.6SWOT and Competitive Positioning
13.5i-SENS
13.5.1Company Overview
13.5.2Relevant Product and Service Portfolio
13.5.3Financial Performance (Where Disclosed)
13.5.4Geographic Presence
13.5.5Recent Strategic Developments
13.5.6SWOT and Competitive Positioning
13.6Sinocare
13.6.1Company Overview
13.6.2Relevant Product and Service Portfolio
13.6.3Financial Performance (Where Disclosed)
13.6.4Geographic Presence
13.6.5Recent Strategic Developments
13.6.6SWOT and Competitive Positioning
13.7Arkray
13.7.1Company Overview
13.7.2Relevant Product and Service Portfolio
13.7.3Financial Performance (Where Disclosed)
13.7.4Geographic Presence
13.7.5Recent Strategic Developments
13.7.6SWOT and Competitive Positioning
13.8B. Braun
13.8.1Company Overview
13.8.2Relevant Product and Service Portfolio
13.8.3Financial Performance (Where Disclosed)
13.8.4Geographic Presence
13.8.5Recent Strategic Developments
13.8.6SWOT and Competitive Positioning
13.9AgaMatrix
13.9.1Company Overview
13.9.2Relevant Product and Service Portfolio
13.9.3Financial Performance (Where Disclosed)
13.9.4Geographic Presence
13.9.5Recent Strategic Developments
13.9.6SWOT and Competitive Positioning
13.10Trividia Health
13.10.1Company Overview
13.10.2Relevant Product and Service Portfolio
13.10.3Financial Performance (Where Disclosed)
13.10.4Geographic Presence
13.10.5Recent Strategic Developments
13.10.6SWOT and Competitive Positioning
Chapter 14 — Appendix
14.1Market Definitions and Acronyms
14.2Currency and Exchange Rate Assumptions
14.3Forecast Modeling Notes
14.4Source and Data Limitations
14.5Research Disclaimer